Ironwood Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$47,709
$122,060
$85,239
$41,143
Gross Profit
47,249
122,060
85,239
13,711
EBITDA
8,801
76,929
46,645
-10,070
EBIT
8,341
76,454
46,178
-10,549
Net Income
-2,276
40,080
23,599
-37,386
Net Change In Cash
47,709
122,060
85,239
41,143
Free Cash Flow
74,576
47,581
-15,070
19,923
Cash
215,456
140,407
92,852
108,481
Basic Shares
177,764
177,764
161,723
160,974

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$296,151
$351,410
$442,735
$410,596
Gross Profit
294,270
343,858
436,587
409,178
EBITDA
104,652
97,728
197,411
261,438
EBIT
102,771
95,717
195,836
260,020
Net Income
24,017
880
-1,002,239
175,065
Net Change In Cash
296,151
351,410
442,735
410,596
Cost of Revenue
36,074
Free Cash Flow
127,010
103,407
183,154
273,627
Cash
215,456
88,559
92,154
656,203
Basic Shares
177,764
160,084
155,435
186,312

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.01
2025-09-30
$0.24
2025-06-30
$0.14